CompletedNot Applicable

Mil Familias Cohort Establishment: a Study to Understand Determinants of Diabetes and Its Complications Among US Latinos

United States405 participantsStarted 2019-02-01

Plain-language summary

The Mil Familias Cohort Establishment involves enrolling 1000 Latino families with at least one member in the family having type 2 diabetes, including children and youth, and measuring the 5 determinants of human health: genetics, biology, behavior, psychology, and society/environment.

Who can participate

Age range7 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Males or females ≥ 7 years of age at enrollment.
✓. Self-reported Latino heritage.
✓. Co-resides with immediate family member (as defined above) OR self with established diagnosis of Type 2 Diabetes for at least one year prior to enrollment date.
✓. Signed and dated written informed consent by the date of enrollment.
✓. Based on the research staff's judgment, subject or subject's representative must have a good understanding, ability, and willingness to adhere to the protocol, including performance of self-monitored data collection during the wearable device portion.

Exclusion criteria

✕. Life expectancy \< 6 months.
✕. Any active clinically significant physical or mental disease or disorder, which in the investigator's opinion could interfere with the participation of the trial.
✕. Language barriers precluding comprehension of study activities and informed consent.
✕. Participation in other trials involving medication or device within 1 month prior to enrollment.
✕. Known or suspected abuse of alcohol, narcotics, or illicit drugs. -

What they're measuring

Success (evaluated by Yes/No format) recruiting and establishing an observational cohort of 1,000 Latino families with at least one family member living with type 2 diabetes by deploying the methods proven feasible by Mil Familias Operational Pilot.

Timeframe: 3 years

Trial details

NCT IDNCT03830840

SponsorSansum Diabetes Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-03-29

View on ClinicalTrials.gov More Type2 Diabetes Mellitus trials